Experts disagree on whether prostate cancer with a Gleason score of 6 (GS6) should be re-labeled as non-cancerous. Writing in a commentary in the Journal of Clinical Oncology, Scott Eggener, MD, and ...
There is disagreement in the medical community about a proposal to relabel prostate cancer Gleason score 6 (GS6) as non-cancerous, as detailed by recent commentaries in the Journal of Clinical ...
A new Moffitt Cancer Center study suggests a widely used genomic test can more accurately identify which men with early ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback